港股異動丨平安好醫生(01833.HK)漲7.3% 股價再創上市以來新高
格隆匯6月26日丨平安好醫生(01833.HK)漲7.3%,報123.4港元,高見124.8港元再創歷史新高,總市值1317億港元。6月22日,國內知名大數據分析公司Analysys易觀對外發布了《中國互聯網醫療行業年度報告》,根據Analysys易觀統計,2019年中國移動醫療市場規模為1336.88億元,較2018年環比增長35.6%。2020年受疫情影響,市場規模將達2000億,市場增長達46.7%,達2015年以來最高增速。目前頭部廠商鎖定了領域內的大部分流量;在頭部廠商中,平安好醫生活躍人數遙遙領先,已經佔據問診市場80%以上流量。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.